CF Winter Retreat (Virtual)
Friday, March 14 to Sunday, March 16, 2025
The CF Adult Retreat was created to enhance education, positive coping skills, and social support for people who share common experiences with CF. People with CF (18 years or older), their family members and friends are invited to join. Each year, the retreat offers educational presentations by CF experts and special guests, as well as daily exercise, arts and crafts, support group sessions, and much more.
“I sometimes have a really hard time imagining myself what’s possible in my life. I really rely on my peers to show me that things are possible. Moving across the world. Getting a master’s degree. Having children. A lot of this stuff, I just don’t think I would have ever imagined if I didn’t meet other people at this Retreat that are doing it and doing it so well. I’m so grateful I got to attend this year, and I’m definitely going to attend next year.” – Retreat Participant
Thank you to the sponsors of the CF Adult Retreat: Vertex Pharmaceuticals, Devin Wakefield, AbbVie, Kelly Colgan Golf Classic Benefit, and Kriss Benson Memorial Fund.
Embrace: A Retreat for Mothers of Children & Adults with CF
Friday, May 2 to Sunday, May 4, 2025
Vallombrosa Center, Menlo Park, CA
Through art workshops, yoga, journaling, CF resources, and respite time, CFRI’s Embrace Mothers Retreat offers an opportunity for women who share the CF path to connect and rejuvenate.
CFRI hosts this annual retreat for mothers of children and adults diagnosed with cystic fibrosis, in recognition of the vital role that mothers have in the care of their loved ones. Studies show that mothers of children with cystic fibrosis have extremely high rates of anxiety and depression, and that this may have a direct impact on their children’s adherence to their medical regimen.
“This retreat was life changing! It is so wonderful to be with other women who understand the challenges we face raising our children with CF.” – Mother of an adult daughter with CF
Embrace Mothers Retreat is sponsored by Vertex Pharmaceuticals and AbbVie.